Animal and in vitro studies maintain that gamma aminobutyric acid (GABA) and glutamic acid decarboxylase (GAD) play fundamental metabolic roles in the pancreas and may be potential therapeutic targets in T1D. The gene discussed is GAD1; the disease is type 1 diabetes mellitus.